Fujifilm India Pvt. Ltd., one of leading Imaging technology firms in India on Thursday reported 12 percent growth with overall net sales of Rs. 1,003 Crores. The Company had recorded overall revenue of Rs 899 crores in FY2014. Medical Systems, Photo Imaging and Graphic Arts continued to be the major growth drivers for the company. FY 2015-16 was indeed a phenomenal year for Fujifilm India as it launched various new products including the Instax range of instant cameras for the Indian market. Also Read - Ola to offer free oxygen concentrators to the needy
The Instax is a well-accepted product worldwide and is now gradually being accepted in India as well. Fujifilm certainly sees much scope for the Instax in India. In Medical Systems, the Company had introduced its state of the art Amulet Innovality- a highly advanced breast cancer diagnostic machine enabling early detection of breast cancer with its 50 Micron 3D image quality and advanced tomosynthesis technology. Also Read - Fujifilm Instax Square SQ1 camera review: Just for fun, not for geeks
Fujifilm India has already installed this product in many top private and government hospitals in India and is promoting the importance of early detection. In Graphic Arts, the company opened its First Demo Centre showcasing its Wide Format Inkjet (WFIJ) printers and their multiple applications in Mumbai last Fiscal.
Speaking on the occasion, Yasunobu Nishiyama, managing director, Fujifilm India said: “We are extremely delighted to report yet another successful year for us. We are witnessing a promising future for ourselves in the Indian market and the FY15 success can be largely attributed to our innovative products and long term commitment towards our customers and partners. I am confident that we will continue to grow and dominate an even larger share in the respective divisions. We are very excited on our India journey and look forward to achieve 20 percent growth in FY2016.”